News Focus
News Focus
Replies to #69746 on Biotech Values
icon url

rkrw

12/09/08 3:30 PM

#69750 RE: DewDiligence #69746

Mrk did say they expect 5 more in pivotal studies by 2012. epo is just first. I wouldn't call it flagship. Merck name provides credibility. Who would you rather provide your generic epo, Insmed or Merck?

The company that's screwed by this is Affymax.